logo
Select company
Select metric
Ticker Information

Ticker

XCUR

Company Name

EXICURE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

EXICURE INC - Enterprise Value over EBITDA Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XCUR - EV/EBITDA Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)Enterprise ValueEnterprise Value over EBITDA
6/30/2025$ -7.21M$ 39.21M0
3/31/2025$ -5.11M$ 26.82M0
12/31/2024$ -8.85M$ 71.05M0
9/30/2024$ -3.17M$ 12M0
6/30/2024$ -7.23M$ 10.38M0
3/31/2024$ -12.19M$ 8.21M0
12/31/2023$ -15.54M$ 9.32M0
9/30/2023$ 4.81M$ 9.8M2.04
6/30/2023$ 5.04M$ 11.46M2.27
3/31/2023$ 3.38M$ 8.4M2.48
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EXICURE INC's latest trailing twelve months (TTM) EV/EBITDA stands at 0.
  • Over the past 5 years, EXICURE INC's average EV/EBITDA has been 20.03.
  • The median EV/EBITDA for EXICURE INC during this period was 2.38
  • EXICURE INC reached its highest EV/EBITDA over the past 5 years at 73.33.
  • The lowest EV/EBITDA recorded by EXICURE INC in the same timeframe 2.04

Definition of Enterprise Value over EBITDA

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
EV / EBITDA
(=) EV/EBITDA
EV/EBITDA for EXICURE INC is calculated as follows: EV [ $ 146.65M ] / EBITDA [ $ -20.39M ]
(=) EV/EBITDA [ 0 ]

XCUR - Enterprise Value over EBITDA, Last 5 years

2.04

Minimum

Sep 30, 2023

73.33

Maximum

Dec 31, 2022

20.03

Average

2.38

Median

EV/EBITDA Benchmark Analysis

The chart above depicts the distribution of EV/EBITDA for companies in the Total Stock Market. The average EV/EBITDA of the companies is 13.48 with a standard deviation of 7.65.
The following table provides additional summary stats:
EV/EBITDA in the Market:
filtered constituents2.44K
min0.01
max40.82
average13.48
median11.75
std7.65